Simply Solventless Concentrates Past Earnings Performance
Past criteria checks 3/6
There is insufficient data on Simply Solventless Concentrates's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals Industry Growth | 23.1% |
| Revenue growth rate | 51.0% |
| Return on equity | 15.9% |
| Net Margin | 11.7% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Simply Solventless Concentrates makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 7 | 1 | 2 | 0 |
| 31 Dec 23 | 6 | 1 | 1 | 0 |
| 30 Sep 23 | 7 | 0 | 1 | 0 |
| 30 Jun 23 | 6 | 1 | 1 | 0 |
| 31 Mar 23 | 4 | -1 | 1 | 0 |
| 31 Dec 22 | 3 | -2 | 1 | 0 |
| 31 Dec 21 | 1 | -2 | 2 | 0 |
Quality Earnings: HASH has high quality earnings.
Growing Profit Margin: HASH became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HASH has become profitable over the past 5 years.
Accelerating Growth: HASH has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: HASH has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (22%).
Return on Equity
High ROE: HASH's Return on Equity (15.9%) is considered low.